BIA-ALCL
Also written as: BIA-ALCL — breast implant-associated anaplastic large cell lymphoma
Acronym for breast implant-associated anaplastic large cell lymphoma, a rare cancer linked to textured breast implants.
Full Definition
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a rare type of T-cell lymphoma that can develop in the scar tissue and fluid surrounding breast implants. This condition is strongly associated with textured surface implants rather than smooth implants. BIA-ALCL typically presents as a late seroma (fluid collection around the implant) occurring more than one year after implantation, though it can also present as a mass or capsular contracture. The condition has led to recalls of certain textured implants and increased scrutiny of implant safety. Early detection and treatment through complete implant and capsule removal generally result in good outcomes, but advanced cases may require additional cancer treatment.
Usage
Usage note: Always spell out the full term on first use in patient documentation due to the serious nature of this diagnosis.
In Context
- "The patient developed BIA-ALCL three years after receiving textured breast implants, presenting as a late seroma." — case report
- "All patients with textured implants should be counseled about the risk of BIA-ALCL and monitored for late seromas." — patient information document